These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Community-acquired pneumonia guidelines: Peering back through the looking glass...clearly? Peterson MW; Hornick DB Am J Med; 2004 Nov; 117(10):799-800. PubMed ID: 15541330 [No Abstract] [Full Text] [Related]
6. Empiric antibiotic prescribing for patients with community-acquired pneumonia: where can we improve? Buising KL; Thursky KA; Black JF; Macgregor L; Street AC; Kennedy MP; Brown GV Intern Med J; 2008 Mar; 38(3):174-7. PubMed ID: 18290813 [TBL] [Abstract][Full Text] [Related]
7. Drug not considered a first-line agent. Lexchin J Can Fam Physician; 1998 Nov; 44():2376. PubMed ID: 9839049 [No Abstract] [Full Text] [Related]
8. [The role of "respiratory" fluoroquinolones in current antibacterial treatment of extrahospital pneumonia]. Sinopal'nikov AI Ter Arkh; 2002; 74(4):80-5. PubMed ID: 12043253 [No Abstract] [Full Text] [Related]
10. [Indications for use of fluoroquinolones in the treatment of community acquired pneumonia]. Mensa J; Martínez JA; Sánchez F; Marcos MA Enferm Infecc Microbiol Clin; 1998 Dec; 16 Suppl 2():31-5; discussion 47-52. PubMed ID: 10344096 [No Abstract] [Full Text] [Related]
11. Novel targets in the management of pneumonia. Díaz LA; Mortensen EM; Anzueto A; Restrepo MI Ther Adv Respir Dis; 2008 Dec; 2(6):387-400. PubMed ID: 19124384 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial prescription patterns for children hospitalized with pneumonia and compliance to guidelines in Japan: a multicenter study. Sasaki H; Imanaka Y; Sekimoto M; Lee J; Otsubo T J Eval Clin Pract; 2010 Oct; 16(5):987-9. PubMed ID: 20626540 [No Abstract] [Full Text] [Related]